Chih-Kang Chiang Selected Research

Transcription Factor CHOP

12/2021	Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
4/2016	C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease.
4/2016	Chemical chaperon 4-phenylbutyrate protects against the endoplasmic reticulum stress-mediated renal fibrosis in vivo and in vitro.
11/2013	C/EBP homologous protein deficiency aggravates acute pancreatitis and associated lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Kang Chiang Research Topics

Disease

15	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 11/2004
15	Inflammation (Inflammations) 12/2020 - 11/2004
14	Fibrosis (Cirrhosis) 12/2021 - 01/2011
12	Chronic Renal Insufficiency 12/2021 - 11/2011
8	Neoplasms (Cancer) 01/2016 - 01/2006
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 01/2007
6	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2012
6	Ureteral Obstruction 06/2022 - 01/2011
6	Malnutrition (Nutritional Deficiencies) 01/2016 - 05/2006
6	Peritonitis 05/2015 - 04/2008
6	Infections 03/2012 - 01/2005
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 10/2015
4	Reperfusion Injury 06/2022 - 11/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 06/2013
4	Vascular Calcification 01/2021 - 06/2014
4	Kidney Diseases (Kidney Disease) 01/2018 - 01/2012
4	Carcinoma (Carcinomatosis) 11/2015 - 01/2012
4	Hypoxia (Hypoxemia) 03/2015 - 11/2011
4	Anemia 01/2015 - 01/2006
3	Ischemia 11/2022 - 01/2013
3	Wounds and Injuries (Trauma) 06/2022 - 01/2013
3	Chronic Disease (Chronic Diseases) 12/2020 - 01/2016
3	Atrophy 01/2018 - 02/2016
3	Hyperphosphatemia 01/2017 - 01/2014
3	Peritoneal Fibrosis 01/2012 - 12/2008
3	Periodontal Diseases (Periodontal Disease) 12/2011 - 05/2006
3	Periodontitis 12/2011 - 05/2006
2	Frailty 01/2020 - 01/2016
2	Heart Failure 01/2019 - 01/2007
2	Diabetes Mellitus 02/2018 - 07/2014
2	Sarcopenia 01/2018 - 01/2018
2	Hypertrophy 01/2018 - 04/2016
2	Muscular Atrophy (Muscle Atrophy) 01/2018 - 02/2016
2	Fatigue 01/2016 - 08/2008
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2015 - 08/2015
2	Herpes Zoster 10/2015 - 12/2014
2	Secondary Hyperparathyroidism 01/2014 - 01/2013
2	Body Weight (Weight, Body) 06/2013 - 01/2013
2	Renal Insufficiency (Renal Failure) 01/2012 - 01/2005
2	Hypertension (High Blood Pressure) 07/2011 - 01/2005
2	Insulin Resistance 06/2010 - 01/2007
2	Weight Gain 03/2008 - 01/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2005
6	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2005
6	Interleukin-6 (Interleukin 6)IBA 11/2013 - 01/2005
5	Advanced Glycation End ProductsIBA 01/2019 - 10/2015
5	CollagenIBA 04/2016 - 01/2009
5	Erythropoietin FDA Link 02/2013 - 01/2006
5	Interleukin-18 (Interleukin 18)IBA 08/2008 - 11/2004
4	Uremic ToxinsIBA 12/2021 - 01/2012
4	Transcription Factor CHOPIBA 12/2021 - 11/2013
4	IndicanIBA 12/2021 - 01/2012
4	CreatinineIBA 01/2016 - 01/2013
4	Vitamin D FDA LinkGeneric 10/2015 - 01/2013
3	CCAAT-Enhancer-Binding ProteinsIBA 12/2021 - 04/2016
3	C-Reactive ProteinIBA 12/2021 - 05/2017
3	Angiopoietin-2IBA 12/2021 - 01/2013
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	PPAR gammaIBA 02/2018 - 01/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2018 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 12/2008
3	AMP-Activated Protein KinasesIBA 02/2016 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2015 - 01/2013
3	AlbuminsIBA 07/2014 - 05/2006
3	CytokinesIBA 11/2013 - 08/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 01/2005
2	QuercetinIBA 11/2022 - 11/2014
2	Therapeutic UsesIBA 11/2022 - 01/2020
2	Pentoxifylline (Trental)FDA LinkGeneric 12/2021 - 01/2012
2	superoxide dismutase 2IBA 01/2021 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2017
2	Superoxide DismutaseIBA 02/2018 - 01/2016
2	AntioxidantsIBA 02/2018 - 01/2016
2	Glutathione Peroxidase GPX1IBA 02/2018 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2018 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2015
2	Atorvastatin (Lipitor)FDA Link 05/2017 - 01/2009
2	Adenosine Triphosphate (ATP)IBA 04/2016 - 10/2015
2	Connective Tissue Growth FactorIBA 04/2016 - 01/2011
2	JNK Mitogen-Activated Protein KinasesIBA 11/2015 - 01/2011
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2015 - 01/2015
2	pevonedistatIBA 11/2015 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 11/2015 - 01/2015
2	EnzymesIBA 01/2015 - 06/2010
2	InterleukinsIBA 11/2013 - 01/2005
2	cobaltous chloride (cobalt(II)chloride)IBA 02/2013 - 11/2011
2	Celecoxib (Celebrex)FDA Link 01/2013 - 01/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2013 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2012 - 11/2011
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2010 - 01/2009
1	Adenine FDA LinkGeneric 06/2022
1	Nonesterified Fatty Acids (NEFA)IBA 04/2022
1	Organic Anion TransportersIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	AST 120IBA 12/2021

Therapy/Procedure

22	Renal Dialysis (Hemodialysis) 01/2016 - 01/2005
16	Peritoneal Dialysis 05/2017 - 10/2002
5	Therapeutics 01/2021 - 01/2010
2	Nephrectomy 12/2021 - 06/2014
2	Catheters 05/2015 - 05/2013